Actively Recruiting
Multicenter Registry of Atrial Fibrillation Ablation With Radiofrequency Balloon Catheter
Led by Universitair Ziekenhuis Brussel · Updated on 2024-03-27
2000
Participants Needed
1
Research Sites
517 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) "Heliostar" (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a real-world setting.
CONDITIONS
Official Title
Multicenter Registry of Atrial Fibrillation Ablation With Radiofrequency Balloon Catheter
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Symptomatic atrial fibrillation with an indication for catheter ablation
You will not qualify if you...
- Age under 18 years old
- Pregnancy
- Any contraindications to catheter ablation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UZ Brussel Heart Rhythm Management Center
Brussels, Belgium, 1090
Actively Recruiting
Research Team
A
Alexandre Almorad, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here